Daniel Nettersheim
Overview
Explore the profile of Daniel Nettersheim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
1119
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kotthoff M, Skowron M, Bremmer F, Parmaksiz F, Kretschmer P, Stephan A, et al.
Int J Cancer
. 2025 Mar;
PMID: 40025812
Relapsing germ cell tumor (GCT) patients often harbor components of the aggressive subtype yolk-sac tumor (YST), suggesting that YST formation is an escape mechanism under therapy. Nevertheless, the molecular mechanisms...
2.
Fichtner A, Zschabitz S, Nettersheim D, Bremmer F
Surg Pathol Clin
. 2025 Jan;
18(1):63-74.
PMID: 39890310
Testicular germ cell tumors (TGCTs) are a heterogeneous group of tumors that occur more commonly in adolescent and adult men. Depending on their age of onset, biological behavior, morphologic characteristics,...
3.
Weiten R, Engler T, Schorle H, Ellinger J, Saponaro M, Alajati A, et al.
J Cell Mol Med
. 2024 Dec;
28(24):e70314.
PMID: 39706819
Cisplatin is used to treat a variety of malignancies, including testicular germ cell tumours (TGCTs). Although cisplatin-based chemotherapy yields high response rates, a subset of patients develop cisplatin resistance, limiting...
4.
Fichtner A, Nettersheim D, Bremmer F
Aktuelle Urol
. 2024 Sep;
55(6):528-536.
PMID: 39236760
Germ cell tumours (GCT) are the most common testicular tumours and form a heterogenous group of tumours with different biological behaviour. Based on differences regarding patient age at first manifestation,...
5.
Moschidou D, Mukherjee S, Blundell M, Drews K, Jones G, Abdulrazzak H, et al.
Mol Ther
. 2024 Aug;
32(8):2798.
PMID: 39122329
No abstract available.
6.
Fichtner A, Nettersheim D, Bremmer F
Histopathology
. 2024 Jun;
85(5):701-715.
PMID: 38922953
Testicular germ cell tumours (GCT) are divided into three different subtypes (types I-III) regarding to their developmental origin, histological differences and molecular features. Type I GCT develop from disturbed primordial...
7.
Stephan A, Suhrmann J, Skowron M, Che Y, Poschmann G, Petzsch P, et al.
Matrix Biol
. 2024 Jun;
132:10-23.
PMID: 38851302
Germ cell tumors (GCT) are the most common solid tumors in young men of age 15 - 40. In previous studies, we profiled the interaction of GCT cells with cells...
8.
Muller M, Burmeister A, Skowron M, Stephan A, Sohngen C, Wollnitzke P, et al.
Exp Cell Res
. 2024 May;
439(1):114055.
PMID: 38704080
Background: Being implicated during tumor migration, invasion, clonogenicity, and proliferation, the nicotinamide adenine dinucleotide (NAD)/-phosphate (NADP)-dependent dehydrogenase/reductase member 2 (DHRS2) has been considered to be induced upon inhibition of histone...
9.
Schmitt L, Lechtenberg I, Driessen D, Flores-Romero H, Skowron M, Sekeres M, et al.
Cell Death Discov
. 2024 Mar;
10(1):125.
PMID: 38461295
Meriolin derivatives represent a new class of kinase inhibitors with a pronounced cytotoxic potential. Here, we investigated a newly synthesized meriolin derivative (termed meriolin 16) that displayed a strong apoptotic...
10.
Pongratanakul P, Bremmer F, Pauls S, Poschmann G, Kresbach C, Parmaksiz F, et al.
Cancer Lett
. 2024 Jan;
585:216673.
PMID: 38296184
In germ cell tumors (GCT), a growing teratoma during chemotherapy with decreasing tumor markers was defined as 'growing teratoma syndrome' (GTS) by Logothetis et al. in 1982. So far, its...